NUVATION BIO INC's ticker is NUVB and the CUSIP is 67080N101. A total of 125 filers reported holding NUVATION BIO INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $3,327,358 | -19.8% | 1,139,506 | -0.0% | 0.00% | 0.0% |
| Q1 2024 | $4,148,966 | +246.0% | 1,139,826 | +43.5% | 0.00% | – |
| Q4 2023 | $1,199,103 | +116.9% | 794,108 | +92.5% | 0.00% | – |
| Q3 2023 | $552,821 | -38.8% | 412,553 | -17.7% | 0.00% | – |
| Q2 2023 | $902,694 | +36.6% | 501,497 | +26.0% | 0.00% | – |
| Q1 2023 | $660,914 | +42.7% | 398,141 | +65.1% | 0.00% | – |
| Q4 2022 | $463,008 | +37851.5% | 241,150 | -55.7% | 0.00% | – |
| Q3 2022 | $1,220 | +159.6% | 544,347 | +275.3% | 0.00% | – |
| Q2 2022 | $470 | -100.0% | 145,046 | -79.8% | 0.00% | -100.0% |
| Q1 2022 | $3,769,000 | +202.0% | 716,445 | +387.9% | 0.00% | – |
| Q4 2021 | $1,248,000 | +129.0% | 146,848 | +168.1% | 0.00% | – |
| Q3 2021 | $545,000 | -63.7% | 54,773 | -66.0% | 0.00% | – |
| Q2 2021 | $1,502,000 | -34.8% | 161,329 | -26.8% | 0.00% | -100.0% |
| Q1 2021 | $2,302,000 | – | 220,293 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 15,247,340 | $49,401,000 | 15.77% |
| Aisling Capital Management LP | 2,541,009 | $8,233,000 | 5.87% |
| EDBI Pte Ltd | 1,270,504 | $4,116,000 | 3.82% |
| Ally Bridge Group (NY) LLC | 1,137,152 | $3,684,000 | 3.36% |
| Deep Track Capital, LP | 11,471,281 | $37,167,000 | 2.44% |
| EcoR1 Capital, LLC | 13,896,543 | $45,025,000 | 1.55% |
| Boxer Capital, LLC | 4,341,009 | $14,065,000 | 0.89% |
| Baupost Group | 10,418,194 | $33,755,000 | 0.50% |
| Redmile Group, LLC | 3,471,709 | $11,248,000 | 0.43% |
| 683 Capital Management, LLC | 1,766,657 | $5,724,000 | 0.40% |